Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mathias Christgen"'
Autor:
Ronald E. Kates, Laura Barberá, Miriam Cuatrecasas, Nadia Harbeck, Oleg Gluz, Fara Brasó-Maristany, Patricia Villagrasa, Tommaso Giarratano, Dolors Soy, Maria Vidal, Tomás Pascual, David Pesantez, Vassilena Tsvetkova, Patricia Galván, Aleix Prat, Hans Kreipe, Laia Paré, Mathias Christgen, Montserrat Muñoz, Barbara Adamo, Inés Monge-Escartín, Blanca Gonzalez-Farre, Maria Vittoria Dieci, D. Martinez, Pierfranco Conte, Tamara Saurí, Valentina Guarneri, Nuria Chic, Gaia Griguolo
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Cancers, Vol 12, Iss 1902, p 1902 (2020)
Cancers
Volume 12
Issue 7
Universidad de Barcelona
Cancers, Vol 12, Iss 1902, p 1902 (2020)
Cancers
Volume 12
Issue 7
Trastuzumab emtansine (T-DM1) is approved for the treatment of human epidermal growth factor receptor 2 (HER2)-positive (HER2+) metastatic breast cancer (BC) and for residual disease after neoadjuvant therapy
however, not all patients benefit. H
however, not all patients benefit. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b95522a064c1502a80af4150f0652a
http://hdl.handle.net/2445/174260
http://hdl.handle.net/2445/174260
Autor:
Jochen Gaedcke, Helmut Ostertag, Frank Traub, Reinhard von Wasielewski, Simone Milde, Alexandru C. Stan, Hans Kreipe, Ludwig Wilkens, Mathias Christgen
Publikováno v:
Modern Pathology. 20:864-870
Although breast cancer is the second most common cause of central nervous system (CNS) metastases with a notable increase of incidence, only few studies on brain-metastasizing breast cancer are available. In this immunohistochemical and fluorescence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04e4fb9c386a1edebd1fb997dfc2f23
https://doi.org/10.1038/modpathol.3800830
https://doi.org/10.1038/modpathol.3800830
